
Sign up to save your podcasts
Or


A controversial field of research is "gain-of-function," in which scientists take a virus (like a strain of flu) and attempt to make it more dangerous, for example by making it transmissible in mammals when it had previously been solely an avian flu. The motivation is to learn how viruses might mutate in nature so that we can be prepared -- but what if those engineered "superbugs" escape the lab and start a pandemic? In this episode of Rationally Speaking, Harvard professor of epidemiology Marc Lipsitch argues that the risks outweigh the benefits, and that we should halt gain-of-function research as soon as possible.
Marc Lipsitch is Professor of Epidemiology with primary appointment in the Department of Epidemiology and a joint appointment in the Department of Immunology and Infectious Diseases. He directs the Center for Communicable Disease Dynamics, a center of excellence funded by the MIDAS program of NIH/NIGMS. He is also the Associate Director of the Interdisciplinary Concentration in Infectious Disease Epidemiology.
By New York City Skeptics4.6
704704 ratings
A controversial field of research is "gain-of-function," in which scientists take a virus (like a strain of flu) and attempt to make it more dangerous, for example by making it transmissible in mammals when it had previously been solely an avian flu. The motivation is to learn how viruses might mutate in nature so that we can be prepared -- but what if those engineered "superbugs" escape the lab and start a pandemic? In this episode of Rationally Speaking, Harvard professor of epidemiology Marc Lipsitch argues that the risks outweigh the benefits, and that we should halt gain-of-function research as soon as possible.
Marc Lipsitch is Professor of Epidemiology with primary appointment in the Department of Epidemiology and a joint appointment in the Department of Immunology and Infectious Diseases. He directs the Center for Communicable Disease Dynamics, a center of excellence funded by the MIDAS program of NIH/NIGMS. He is also the Associate Director of the Interdisciplinary Concentration in Infectious Disease Epidemiology.

32,008 Listeners

38,482 Listeners

228,910 Listeners

30,680 Listeners

38,842 Listeners

26,233 Listeners

14,326 Listeners

2,452 Listeners

12,220 Listeners

112,277 Listeners

908 Listeners

15,918 Listeners

1,682 Listeners